Health Care

Commentary

As PBMs Drive Up Drug Prices, Silence Is Not Golden

The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
Commentary

A Promising New AIDS Drug Highlights The Dangers Of Price Controls

The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
Commentary

Let the Message Be Clear: Canadian Healthcare Failed

Meet Mary, a 60-year-old woman from British Columbia. She needed a colonoscopy to confirm her cancer diagnosis. Mary spent four months on a waiting list. Then her bowel ruptured, and she suffered life-threatening sepsis. Due to the delay in treating her cancer, she had to get chemotherapy, which came with ...
Commentary

Trump tackles waste, fraud, and abuse in Obamacare

The Trump administration earlier this month finalized a rule that aims to stop waste, fraud, and abuse in the federally subsidized Obamacare exchanges. It’s about time. Millions of people who don’t qualify for free health coverage are receiving it on the public’s dime. The new rule will restore some measure ...
Commentary

Democrats Should Be Honest About Healthcare Waste and Fraud

For weeks, opponents of Republicans’ One Big Beautiful Bill Act have portrayed it as a threat to health coverage for millions of Americans. Some critics have said that it would covertly repeal Obamacare. If only. The bill is hardly a radical assault on health coverage. It would finally crack down ...
Commentary

Congress Can Help Small Businesses Afford Health Insurance

Health insurance is more expensive than ever. The average family plan last year cost employers and employees over $19,000 and nearly $6,300 per year, respectively. That’s enough to buy a new car. Congressional Republicans’ budget reconciliation bill could help bring down those costs. Among other things, the One Big Beautiful ...
Commentary

Price Controls On Doctors Are Costing Patients Dearly

Just like the December 2024 continuing resolution, the current budget reconciliation bill fails to address the problem of Medicare reimbursing physicians at below market rates. Without a fix, the inevitable consequences will be worsening doctor shortages, declining healthcare quality, higher overall healthcare spending, and the accelerated loss of independent practices. ...
Commentary

Physician-Assisted Suicide Is A Bigger Problem Than We Realize

Dovie Eisner was born with a rare genetic condition called nemaline myopathy. He requires a wheelchair and has a host of other health problems. Last year at one point, he stopped breathing, passed out on the street, and was taken to the emergency room. “I was alive—thanks to the determination ...
Commentary

What’s So Scary About Medicare Reform?

One of the biggest questions surrounding Senate Republicans’ version of the One Big Beautiful Bill Act concerns the fate of Medicare. Earlier this month, GOP lawmakers were reportedly considering reforms aimed at reducing waste, fraud and abuse in the entitlement as a way to deliver savings for taxpayers. But as ...
Commentary

A Real and Present Threat to Alzheimer’s Patients

It’s a quintessential government outcome. A program intended to increase access to promising medical innovations is actually preventing Medicare beneficiaries from receiving FDA-approved treatments. Medicare’s “coverage with evidence development” (CED) was never authorized by Congress. Instead, the Centers for Medicare & Medicaid Services created the program in 2005 by leveraging ...
Commentary

As PBMs Drive Up Drug Prices, Silence Is Not Golden

The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
Commentary

A Promising New AIDS Drug Highlights The Dangers Of Price Controls

The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
Commentary

Let the Message Be Clear: Canadian Healthcare Failed

Meet Mary, a 60-year-old woman from British Columbia. She needed a colonoscopy to confirm her cancer diagnosis. Mary spent four months on a waiting list. Then her bowel ruptured, and she suffered life-threatening sepsis. Due to the delay in treating her cancer, she had to get chemotherapy, which came with ...
Commentary

Trump tackles waste, fraud, and abuse in Obamacare

The Trump administration earlier this month finalized a rule that aims to stop waste, fraud, and abuse in the federally subsidized Obamacare exchanges. It’s about time. Millions of people who don’t qualify for free health coverage are receiving it on the public’s dime. The new rule will restore some measure ...
Commentary

Democrats Should Be Honest About Healthcare Waste and Fraud

For weeks, opponents of Republicans’ One Big Beautiful Bill Act have portrayed it as a threat to health coverage for millions of Americans. Some critics have said that it would covertly repeal Obamacare. If only. The bill is hardly a radical assault on health coverage. It would finally crack down ...
Commentary

Congress Can Help Small Businesses Afford Health Insurance

Health insurance is more expensive than ever. The average family plan last year cost employers and employees over $19,000 and nearly $6,300 per year, respectively. That’s enough to buy a new car. Congressional Republicans’ budget reconciliation bill could help bring down those costs. Among other things, the One Big Beautiful ...
Commentary

Price Controls On Doctors Are Costing Patients Dearly

Just like the December 2024 continuing resolution, the current budget reconciliation bill fails to address the problem of Medicare reimbursing physicians at below market rates. Without a fix, the inevitable consequences will be worsening doctor shortages, declining healthcare quality, higher overall healthcare spending, and the accelerated loss of independent practices. ...
Commentary

Physician-Assisted Suicide Is A Bigger Problem Than We Realize

Dovie Eisner was born with a rare genetic condition called nemaline myopathy. He requires a wheelchair and has a host of other health problems. Last year at one point, he stopped breathing, passed out on the street, and was taken to the emergency room. “I was alive—thanks to the determination ...
Commentary

What’s So Scary About Medicare Reform?

One of the biggest questions surrounding Senate Republicans’ version of the One Big Beautiful Bill Act concerns the fate of Medicare. Earlier this month, GOP lawmakers were reportedly considering reforms aimed at reducing waste, fraud and abuse in the entitlement as a way to deliver savings for taxpayers. But as ...
Commentary

A Real and Present Threat to Alzheimer’s Patients

It’s a quintessential government outcome. A program intended to increase access to promising medical innovations is actually preventing Medicare beneficiaries from receiving FDA-approved treatments. Medicare’s “coverage with evidence development” (CED) was never authorized by Congress. Instead, the Centers for Medicare & Medicaid Services created the program in 2005 by leveraging ...
Scroll to Top